Clik here to view.
Is FDA Watching YouTube?
Two weeks ago, Shire received a warning letter for posting a sponsored testimonial on YouTube without including risk information. Shire was very open when I called them up and admitted that the video...
View ArticleAmid Big Pharma Woes, Shire in “Best Shape Everâ€
Angus Russell, Shire’s longtime CFO—now CEO—likens the failing US automobile industry to pharma. “All the problems with the automobile industry were a long time coming,†he says. “It’s...
View ArticleVertex Names Emmens President, Future CEO
Vertex Pharmaceuticals Thursday appointed Matthew Emmens president, with an expected transition to CEO and chairman in May 2009, when current CEO Joshua Boger is set to retire. Emmens, a 35-year pharma...
View ArticleClik here to view.
Feds Threaten to Pull ProAmatine for Lack of Postmarket Data (Updated 8/18)
Image via Wikipedia FDA on Monday announced that it was looking to withdraw approval for the low-blood-pressure treatment midodrine hydrochloride because the companies manufacturing the drug failed to...
View ArticleClik here to view.
Promotional Review Committees: How to Achieve High Performing Teams
by Arthur Lazarus What does it take for internal Promotional Review Committees to function at their best and avoid costly mistakes to the company? A leading industry practitioner offers 15 tips for...
View ArticleClik here to view.
Suffer Little Children? To Medicate or Not to Medicate Toddlers
When Audre McDonald accepted her sixth Tony Award (theater’s version of the Academy Awards) this month in New York City, and broadcast live on national television, she thanked her parents “for their...
View ArticleClik here to view.
The Rx Firm Tax Exodus: Is Something Wrong with the U.S. System?
As I read the latest reports of yet another big US Rx firm, this time AbbVie, trying to pull off a “tax inversion” takeover of the Irish-based Shire, I couldn’t help but wonder, what the heck is going...
View ArticleShire Takeover "Could Save AbbVie $8 Billion Tax on Humira over Next 15 Years"
AbbVie’s recent $54 billion acquisition of Shire and subsequent relocation to Ireland will mean substantial tax savings for the US pharmaceutical giant, according to analysts at research and consulting...
View ArticlePharma Feels Impact of US Tax Inversion Legislation
The recent termination of AbbVie’s deal to acquire Shire has “jolted the industry out of its reverie” by becoming pharma’s first major casualty of new US tax inversion legislation, says research and...
View ArticleShire to Relocate More Than 500 Jobs to Lexington, MA
Shire plans to relocate more than 500 positions to Massachusetts from its Chesterbrook, PA, site and establish Lexington, MA, as the company’s US operational headquarters. The transition is a...
View Article
